MedCap AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
For the six months, sales was SEK 546.9 million compared to SEK 456 million a year ago. Revenue was SEK 552 million compared to SEK 460.1 million a year ago. Net income was SEK 40.6 million compared to SEK 29.6 million a year ago. Basic earnings per share was SEK 2.7 compared to SEK 2 a year ago. Diluted earnings per share was SEK 2.7 compared to SEK 2 a year ago.